Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Benzoyl peroxide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for » Acnecide Face Wash contains the active ingredient benzoyl peroxide which kills the bacteria (germs) known as Propionibacterium acnes, one of the main causes of acne.
Moderate
Severe
v x
e Acnecide Face Wash Do not use Acnecide Face Wash if you:
Acnecide Face Wash Always use this medicine exactly as described in this leaflet. Check with your pharmacist or doctor if you are not sure. Benzoyl Peroxide may cause irritation. You should therefore start by using this product on alternate days to minimise this risk and then gradually increase the frequency up to twice a day use if tolerated. If you experience any severe skin irritation stop using the product. If this irritation does not improve after stopping, please consult your pharmacist or doctor.
¢ Unless your pharmacist or doctor has told you otherwise:
Like all medicines, this medicine can cause side effects, although not everybody gets them. STOP using Acnecide Face Wash and tell your doctor immediately if you develop a severe allergic reaction. Signs of severe allergic reaction may include: ¢ Raised and itchy rash (hives) ¢ Swelling of the face, eyes, lips, tongue or mouth (angioedema), having difficulty in breathing
These symptoms are usually reversible if the treatment is reduced in frequency or discontinued. If your skin becomes severly irritated, or severe redness, itching or peeling of the skin occurs, discontinue use immediately and consult your pharmacist or doctor. Reporting of side effects If you get any side effects, talk to your pharmacist or doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.
Acnecide Face Wash
What Acnecide Face Wash contains The active substance is benzoyl peroxide 5% w/w as hydrous benzoyl peroxide in a cleansing gel. The other ingredients are acrylates copolymer, glycerol, carbomer 940,
sodium C_,-C,. olefin sulfonate, sodium hydroxide (for pH adjustment), and purified water. What Acnecide Face Wash looks like and contents of the pack Acnecide Face Wash is a white to off-white gel which is available in a 50g tube. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Galderma (U.K.) Limited, Evergreen House North, Grafton Place, London, England, NW1 2DX (PL 10590/0070) Manufacturer: Laboratoires Galderma, ZI- Montdésir, 74540 Alby-sur-Chéran, France. This leaflet was last revised in 12/2025
7. General advice for people with acne ¢ Try not touch your face too much and do not pick or squeeze your spots as this can make them worse.
Acnecide Face Wash 5% w/w Gel comes as gel. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Acnecide Face Wash 5% w/w Gel is benzoyl peroxide.
Medicines with the same active substance, strength and form include: Acnecide 10% w/w Gel, Acnecide 5% w/w Gel, Acnecide Face 2.5% w/w Gel. In total there are 5 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Acnecide Face Wash 5% w/w Gel, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Acnecide Face Wash is intended for the topical treatment of mild acne affecting the face, where comedones (blackheads and whiteheads) predominate, and there are few or no papules and pustules (acne spots and pimples) and no inflamed spots.
Acnecide Face Wash is indicated in adults and adolescents aged 12 years and over.
Posology:
Adults and adolescents aged 12 years and over:
When first used Acnecide Face Wash should be applied once daily to cover the acne- affected skin areas before going to bed. After 2-3 days, if the treatment is well tolerated, the frequency of application can be increased to twice daily, in the morning and evening. The extent of any drying or peeling may be adjusted by modifying the dosage schedule (see section 4.4).
Paediatric population:
The safety and efficacy of Acnecide Face Wash in children aged less than 12 years have not been established. No data are available.
Method of administration:
For topical administration only
Wet the area to be treated, apply the preparation to the hands and wash the affected area with the gel. Contact time with the skin should be 1 to 2 minutes followed by thorough rinsing with water and drying.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
For external use only.
This product is not suitable for individuals with severe acne (characterised by large numbers of inflamed spots on the face or the presence of nodules and cysts), moderate acne (characterised by papules and pustules) or previous scarring from acne, who should seek treatment advice from a doctor.
Individuals with extensive acne lesions affecting other areas (e.g. the chest shoulders and back), which they want to treat, should consult their pharmacist or doctor. These lesions are often more difficult to treat and topical treatments may not be appropriate if they are widespread.
Individuals with mild acne that are particularly concerned by their condition should consult their doctor.
Acnecide Face Wash may cause swelling and blistering of the skin, if any of these symptoms occur, medication has to be discontinued.
In normal use, a mild burning sensation will probably be felt on first application and a moderate reddening and peeling of the skin will occur within a few days. During the first weeks of treatment a sudden increase in peeling will occur in most people, this is not harmful and will normally subside within a day or two if treatment is temporarily discontinued. Adjunctive use of moisturizers can help to limit the potential for skin irritation.
If severe irritation occurs, individuals should temporarily discontinue use until the irritation subsides. If treatment is restarted, the product should be applied less frequently (i.e. once a day instead of twice daily or alternate days instead of once a day). If severe irritation occurs again after treatment is restarted, discontinue use altogether.
Excessive application will not improve efficacy, but may increase the risk of skin irritation.
In the event of scarring following initial treatment with Acnecide Face Wash, treatment should be discontinued and advice should be sought from a doctor.
Acnecide Face Wash should not come into contact with the eyes, mouth, angles of the nose or mucous membranes. If the preparation enters the eye, wash thoroughly with water. Acnecide Face Wash should not be applied to the neck and other sensitive areas (around the eyes and mouth, angles of the nose or mucous membranes). Due to the risk of sensitisation, Acnecide Face Wash should not be applied to damaged skin.
As Acnecide Face Wash may cause increased sensitivity to sunlight, sunlamps should not be used and deliberate or prolonged exposure to sunlight or UV radiation should be avoided. When strong sunlight cannot be avoided, individuals should use a sunscreen product and wear protective clothing.
Contact with any coloured material including hair and dyed fabrics may result in bleaching or discoloration.
Acnecide Face Wash should not be used in conjunction with other benzoyl peroxide preparations (including other Acnecide products), nor with any other topical or systemic treatment(s) for acne except under medical supervision.
Individuals should cease use and seek medical advice if their condition deteriorates despite therapy or in cases of a lack of response after use for 12 weeks.
No interaction studies have been performed. However, drugs with desquamative, irritant and drying effects should not be used concurrently with Acnecide Face Wash.
Pregnancy
There is no safety concern relating to the effects of cutaneously applied benzoyl peroxide on reproductive function, fertility, teratogenicity, embryotoxicity, or periand post- natal development from animal data. In widespread clinical use for the cutaneous treatment of acne vulgaris, at concentrations up to 10% w/w for several decades, benzoyl peroxide has never been associated with such effects. Acnecide Face Wash should only be used by a pregnant woman under medical supervision.
Breast-feeding
It is unknown whether benzoyl peroxide/metabolites are excreted in human milk. A risk to the new-borns/infants cannot be excluded and the preparation should not be applied on the chest in nursing women to avoid accidental transfer to the infant. Acnecide Face Wash should only be used by a nursing woman under medical supervision.
Acnecide Face Wash has no or negligible influence on the ability to drive and use machines
The adverse reactions resulting from clinical trials are all skin disorders. They are reversible when treatment is reduced in frequency or discontinued.
The following categories are used to indicate the frequency of occurrence of adverse effects:
Very common (≥1/10)
Common (≥1/100 to <1/10)
Uncommon (≥ 1/1,000 to <1/100)
Rare (≥1/10,000 to <1/1,000)
Very rare (<1/10,000)
Unknown (Frequency not assessable based on the available data).
They are presented in the table below:
Skin and subcutaneous tissue disorders
Very common
(≥1/10)
Dry skin, Erythema, Skin exfoliation, (peeling), Skin burning sensation
Common
(≥1/100 to <1/10)
Pruritus, Pain of skin (pain, stinging), Skin irritation, (irritant contact dermatitis)
Uncommon
(≥1/1,000 to <1/100)
Allergic contact dermatitis
Swelling face and allergic reactions, including application site hypersensitivity and anaphylaxis (not known frequency) have been reported during post-marketing surveillance.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard.
Acnecide Face Wash is for topical use only. If the medication is applied excessively, no more rapid or better results will be obtained and severe irritation might develop. In this event, treatment must be discontinued and appropriate symptomatic therapy, including the use of moisturizers, should be instituted.
In the case of accidental ingestion, urgent medical attention is required. Expert advice should be sought and supportive measures instituted.
Ask anything about Acnecide Face Wash 5% w/w Gel. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.